Rinvoq cost?

Rinvoq (upadacitinib) is a prescription drug, and its price varies a lot by country, dosage, and your insurance. Here’s a quick, general picture:

- United States (typical dosing is 15 mg once daily): The list price for a 30‑day supply is usually in the range of about $6,000 to $8,000 before insurance. Your exact out-of-pocket amount depends on your plan’s copay/coinsurance and any discounts.
- With insurance: Many people pay much less than the list price, but it depends on formulary placement, prior authorization, and your plan’s deductible.
- Savings programs: AbbVie offers patient savings programs for Rinvoq to eligible commercially insured patients. There are also discount cards and cash prices at pharmacies (e.g., via GoodRx). Availability and amounts vary, so check Rinvoq’s site or with your pharmacist.
- Other countries: Prices differ by country and local healthcare systems.

If cost is a concern, you can:
- Check the current cash price at your local pharmacy (some have discounted cash prices).
- Look up available discounts or savings programs on Rinvoq’s official site or ask your pharmacist/prescriber.
- Talk to your insurer about coverage, prior authorization, or a more cost-effective option.
- Discuss alternatives with your doctor (other JAK inhibitors or different drug classes) if affordability is a barrier.

If you tell me your country and whether you have insurance, I can give a more tailored estimate or help you compare options.